Trial Profile
A Phase II Trial of Intensive Chemotherapy [temozolomide, busulfan, thiotepa] and Autotransplantation for Patients With Newly Diagnosed Anaplastic Oligodendroglioma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Oct 2023
Price :
$35
*
At a glance
- Drugs Temozolomide (Primary) ; Busulfan; Thiotepa
- Indications Astrocytoma; Glioma; Oligodendroglioma
- Focus Therapeutic Use
- 07 Feb 2023 Status changed from active, no longer recruiting to completed.
- 03 Oct 2022 Planned End Date changed from 1 Sep 2022 to 1 Sep 2023.
- 03 Oct 2022 Planned primary completion date changed from 1 Sep 2022 to 1 Sep 2023.